Episodes (Page 16)
✨
European biotech funding faces challenges due to trade barriers and policy shifts.
✨
Brain+ CEO Devika Wood discusses health tech for dementia.
Devika Wood
✨
EU proposals aim to simplify sustainability rules and boost competitiveness.
Jasper Crone
✨
Big pharma executive pay, US vaccine panel changes, and Merck's RSV approval.
✨
European officials' views on Trump's Most Favored Nation drug pricing proposal.
✨
Entry deadline for Citeline Japan Awards 2025 is July 14.
✨
Biotechs face shrinking funding and uncertain futures.
✨
Biotechs adapt to market challenges using AI and real-world data.
✨
Sanofi's Blueprint acquisition, AstraZeneca's breast cancer results.
✨
Discussion on symptoms, diagnosis, and treatment of Sjögren's disease.
✨
Vinay Prasad stepping away from daily FDA CBER review decisions.
✨
Ketryx launches validated AI agents for medtech compliance automation.
Elizabeth Orr
Marion Webb
Shubham Singh
✨
Generics Bulletin editors discuss the Global Generics & Biosimilars Awards 2025.
✨
Raj Panjabi discusses Flagship's Preemptive Health and Medicine Initiative.
Raj Panjabi
✨
Examining cardiovascular and safety outcomes of SGLT2 inhibitors.
✨
Plant-based diets show improved outcomes in metastatic breast cancer.
✨
Navigating the evolving landscape of hepatology clinical trials.
✨
Preview of major ASCO readouts and Roivant's deal strategy.
✨
France's self-care market is dynamic, driven by community pharmacies.
Luc Besancon
✨
Medtech's Voluntary Improvement Program (VIP) enhances patient safety.